| Ms Marjorie Anne Erl, MS, CCC-SLP | |
|
10134 Old Union Rd, Union, KY 41091-8508 | |
| (859) 301-7232 | |
| (859) 301-7240 |
| Full Name | Ms Marjorie Anne Erl |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 10134 Old Union Rd, Union, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255540886 | NPI | - | NPPES |
| 01013671 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | KY-0136 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Marjorie Anne Erl, MS, CCC-SLP 969 Augusta Ct, Union, KY 41091-7721 Ph: (859) 657-6881 | Ms Marjorie Anne Erl, MS, CCC-SLP 10134 Old Union Rd, Union, KY 41091-8508 Ph: (859) 301-7232 |
News Archive
Almost 12,000 people died in alcohol-related vehicle crashes in 2008. About 15,000 Americans died of AIDS-related illness the same year. Both of these preventable causes of death have been the subject of massive, expensive and high-profile interventions by federal and state authorities. CRE encourages expenditures for these programs but the public health community should be even more concerned for greater society-wide risks.
Current Alzheimer's disease (AD) research indicates that accumulation of amyloid-beta (Aβ) protein plaques in the brain is central to the development of AD.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it was expanding its Phase 2 clinical trial of STA-9090 in patients with Stage IIIB and Stage IV non-small cell lung cancer (NSCLC) from up to 69 patients to up to 146 patients based on encouraging activity observed in the first stage of the two stage clinical trial.
BioTrends Research Group, Inc. released Wave 3 of its LaunchTrends®: Feraheme report, the third in a multi-phase syndicated market research project tracking the launch of AMAG's new IV iron product, Feraheme, through the first six months of product availability. Each wave of the report provides quantitative information from 50 unique Nephrologists and qualitative information from a subset of 15. The reports assess trial and use of Feraheme, obstacles to use, reasons to use, typical patient types, product perceptions, promotional efforts/messages, and product satisfaction.
› Verified 7 days ago
Amy Green, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1094 Bold Forbes Ct, Union, KY 41091 Phone: 203-232-4354 | |
Elizabeth R Rock, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9604 Splendor Dr, Union, KY 41091 Phone: 859-391-1476 | |
Mrs. Theresa Ann Danner, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11003 War Admiral Dr, Union, KY 41091 Phone: 859-250-9024 Fax: 859-689-0198 | |
Mrs. Stacy Shelton Bennett, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10608 Mountain Laurel Way, Union, KY 41091 Phone: 859-209-0944 Fax: 919-294-4500 | |
Mary Erickson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10089 Brandsteade Ct, Union, KY 41091 Phone: 859-496-7788 Fax: 859-384-2775 | |
Barbara Lynn Gifford, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 967 Augusta Ct, Union, KY 41091 Phone: 859-866-1950 Fax: 859-384-1289 |